NCT04426409

Brief Summary

Nasotracheal intubation is one of the anesthetic procedures required for oral surgery. It allows the surgeon easier access to the surgical site than the orthotracheal intubation. Therefore, nosotracheal intubation is commonly used for general anesthesia for oral and maxillofacial surgery and dental treatment. However, nasotracheal intubation can damage the nasal mucosa in the course of the tube passing through the nostrils, causing epistaxis which is reported as the most common side effect. In order to reduce these side effects, heating of the tube and use of a tube lubricant immediately before intubation have been recommended in children. However, research on whether the dry state of the mucosa itself contributes to the development of epistaxis is limited. A study in adults reported that pretreatment of the ointment on the mucosa reduced the damage to the mucosa. However, its effect on the incidence of epistaxis in children has not been studied. The purpose of this study is to investigate the effects of pretreatment of nasal ointment on epistaxis of nasotracheal intubation in children.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 11, 2020

Completed
27 days until next milestone

Study Start

First participant enrolled

July 8, 2020

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

July 26, 2022

Status Verified

July 1, 2022

Enrollment Period

1.2 years

First QC Date

June 8, 2020

Last Update Submit

July 24, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • incidence of epistaxis

    percentage of the development of epistaxis after nasotracheal intubation

    immediate after intubation

  • incidence of epistaxis

    percentage of the development of epistaxis after nasotracheal intubation

    immediate after extubation

Secondary Outcomes (3)

  • severity of epistaxis

    immediate after intubation

  • severity of epistaxis

    immediate after extubation

  • Navigability

    immediate after intubation

Study Arms (2)

control group

NO INTERVENTION

ointment group

EXPERIMENTAL

Ointment group should apply a nasal ointment to both noses using a cotton swab the night before surgery and the morning of surgery.

Drug: tarivid ointment

Interventions

Vaseline ointment is applied to both noses.

ointment group

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • American Society of Anesthesiologists physical statue I or II
  • Patients scheduled to undergo surgery under nasotracheal intubation

You may not qualify if:

  • expected difficult intubation based on history, physical examination, weight.
  • bleeding tendency
  • upper respiratory infection within the previous 14 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ajou University School of Medicine

Suwon, Gyeonggi-do, South Korea

Location

MeSH Terms

Conditions

Epistaxis

Condition Hierarchy (Ancestors)

Nose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsSigns and Symptoms, RespiratorySigns and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 8, 2020

First Posted

June 11, 2020

Study Start

July 8, 2020

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

July 26, 2022

Record last verified: 2022-07

Locations